LA
AMGN icon

Lane & Associates’s Amgen AMGN Stock Holding History

Lane & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$487K Buy
1,563
+64
+4% +$18.9K 0.26% 66
2024
Q4 		$428K Buy
1,499
+85
+6% +$25.2K 0.22% 76
2024
Q3 		$455K Sell
1,414
-15
-1% -$4.91K 0.25% 70
2024
Q2 		$446K Buy
1,429
+123
+9% +$36.1K 0.26% 69
2024
Q1 		$371K Sell
1,306
-77
-6% -$22.5K 0.23% 75
2023
Q4 		$398K Sell
1,383
-45
-3% -$12.3K 0.29% 68
2023
Q3 		$384K Buy
1,428
+21
+1% +$5.24K 0.31% 64
2023
Q2 		$312K Buy
1,407
+216
+18% +$50.1K 0.25% 73
2023
Q1 		$288K Buy
+1,191
New +$292K 0.26% 74

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lane & Associates's AMGN Position: Q1 2025 in Review

Lane & Associates increased its Amgen (AMGN) stake by 4.3% in Q1 2025, buying an estimated $18.9K and bringing the position to 1,563 shares worth $487K. The position accounts for 0.26% of the portfolio, ranked #66.

Lane & Associates first reported a position in AMGN in Q1 2023 and has held it in 9 quarters since. 2,927 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Lane & Associates held 1,563 shares of Amgen worth $487K as of Q1 2025.
  • Lane & Associates bought 64 Amgen shares in Q1 2025, an estimated $18.9K.
  • Amgen made up 0.26% of Lane & Associates's portfolio in Q1 2025, its #66 holding.
  • Lane & Associates first reported a position in Amgen in Q1 2023 and has held it in 9 quarters since.
  • 2,927 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Lane & Associates's 13F filing for Q1 2025, filed 1 May 2025.